- Home
- ARCT vs EQV Comparison
ARCT vs EQV Comparison
Compare ARCT & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- EQV
- Stock Information
- Founded
- ARCT 2013
- EQV 2024
- Country
- ARCT United States
- EQV United States
- Employees
- ARCT N/A
- EQV N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- EQV
- Sector
- ARCT Health Care
- EQV
- Exchange
- ARCT Nasdaq
- EQV Nasdaq
- Market Cap
- ARCT 444.5M
- EQV 446.6M
- IPO Year
- ARCT N/A
- EQV 2024
- Fundamental
- Price
- ARCT $17.77
- EQV $10.02
- Analyst Decision
- ARCT Strong Buy
- EQV
- Analyst Count
- ARCT 7
- EQV 0
- Target Price
- ARCT $63.60
- EQV N/A
- AVG Volume (30 Days)
- ARCT 439.9K
- EQV 68.6K
- Earning Date
- ARCT 03-06-2025
- EQV 01-01-0001
- Dividend Yield
- ARCT N/A
- EQV N/A
- EPS Growth
- ARCT N/A
- EQV N/A
- EPS
- ARCT N/A
- EQV N/A
- Revenue
- ARCT $160,399,000.00
- EQV N/A
- Revenue This Year
- ARCT $6.54
- EQV N/A
- Revenue Next Year
- ARCT $0.25
- EQV N/A
- P/E Ratio
- ARCT N/A
- EQV N/A
- Revenue Growth
- ARCT N/A
- EQV N/A
- 52 Week Low
- ARCT $14.30
- EQV $9.88
- 52 Week High
- ARCT $45.00
- EQV $10.05
- Technical
- Relative Strength Index (RSI)
- ARCT 54.71
- EQV N/A
- Support Level
- ARCT $16.54
- EQV N/A
- Resistance Level
- ARCT $19.25
- EQV N/A
- Average True Range (ATR)
- ARCT 1.19
- EQV 0.00
- MACD
- ARCT 0.14
- EQV 0.00
- Stochastic Oscillator
- ARCT 62.15
- EQV 0.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.